Scientists develop novel technique for finding drugs to combat malaria

2 hours ago by Deirdre Branley Credit: CDC

Each year nearly 600,000 peoplemostly children under age five and pregnant women in sub-Saharan Africadie from malaria, caused by single-celled parasites that grow inside red blood cells. The most deadly malarial speciesPlasmodium falciparumhas proven notoriously resistant to treatment efforts. But thanks to a novel approach developed by scientists at Albert Einstein College of Medicine of Yeshiva University and described in the January 20 online edition of ACS Chemical Biology, researchers can readily screen thousands of drugs to find those potentially able to kill P. falciparum.

Scientists have known for more than a decade that malaria parasites have an Achilles heel: Like all cells, they require two key building blockspurines and pyrimidinesto synthesize their DNA and RNA. But malaria parasites can't synthesize purines on their own. Instead, they must import purines from the host red blood cells that they invade. A parasite protein called PfENT1 transports purines from blood cell into the parasites. So drugs that block PfENT1 could conceivably kill the parasites by depriving them of purines they needbut an experimental approach for identifying PfENT1 inhibitors didn't exist, until now.

Einstein's Myles Akabas, M.D., Ph.D., developed a novel yeast-based high-throughput assay for identifying inhibitors of the PfENT1 transporter. Dr. Akabas worked with two MSTP students in his lab (I.J. Frame and Roman Deniskin) as well as colleagues at Einstein (Drs. Ian Willis and Robyn Moir) and Columbia University (Drs. Donald Landry and David Fidock). The researchers used their technique to screen 64,560 different compounds. They identified 171 potential antimalarial drugs. Studies of nine of the most potent drugs showed that they kill P. falciparum parasites in laboratory culture.

"We've shown that the PfENT1 transporter is a potential drug target for developing novel antimalarial drugs," said Dr. Akabas, senior author of the ACS Chemical Biology paper and a professor of physiology & biophysics, of medicine and in the Dominick P. Purpura Department of Neuroscience at Einstein. "By using our rather simple approach, scientists could create similar high-throughput screens to identify inhibitors for killing other parasites that rely on transporters to import essential nutrients."

Explore further: Malaria-in-a-dish paves the way for better treatments

Massachusetts Institute of Technology (MIT) researchers have engineered a way to use human liver cells, derived from induced pluripotent stem cells, to screen potential antimalarial drugs and vaccines for ...

An antimalarial agent developed by researchers at Albert Einstein College of Medicine of Yeshiva University proved effective at clearing infections caused by the malaria parasite most lethal to humans by literally ...

Malaria is one of the most deadly infectious diseases in the world today, claiming the lives of over half a million people every year, and the recent emergence of parasites resistant to current treatments ...

Scientists searching for new drugs to fight malaria have identified a number of compoundssome of which are currently in clinical trials to treat cancerthat could add to the anti-malarial arsenal.

See the article here:
Scientists develop novel technique for finding drugs to combat malaria